Evan Loh, Paratek CEO
Novo Holdings, Gurnet Point Capital engineer $462M take-private deal for antibiotics player Paratek
Novo Holdings has long invested in companies developing antibiotics. Now, it wants to take the next step: own part of a biotech that already has …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
